Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. NARAIN (Lucknow (Uttar Pradesh), India), R. Dubey (Lucknow (Uttar Pradesh), India), A. Verma (Lucknow (Uttar Pradesh), India), A. Srivastava (Lucknow (Uttar Pradesh), India), S. Kant (Lucknow (Uttar Pradesh), India). Proteasome Accessory Factor-C (PafC) as a potential regulator of mycobacterial survival in multi drug-resistant tuberculosis patients. 1595

Member's Comments

No comment yet.

Related content which might interest you: Construing the role of Proteasome Accessory Factor-C in fluoroquinolone resistance in pulmonary tuberculosis Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 A study to perceive the role and function of Proteasome Accessory Factor-C (PafC) inMycobacterium tuberculosis. Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019 Elucidation of Protein Tyrosine Phosphatase-B for its role in intracellular survival of Mycobacterium tuberculosis Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019 Recurrence after successful treatment of pulmonary tuberculosis (TB) with multidrug-resistance (MDR) Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Induction of M. tuberculosis (MTB) drug resistance (DR) mutations in HIV-infected hosts and pathways of further spread of the evolutionary successful drug-resistant MTB clonal lines Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Deficient in silico selection of mycobacterium tuberculosis (MTB) epitopes in tuberculosis (TB) patients Source: Eur Respir J 2006; 28: Suppl. 50, 801s Year: 2006 Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Expression of P-gP in patients with resistant tuberculosis Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012 Influence of glutoxim and its derivatives on the growth of mycobacterium tuberculosis (Mtb) Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 Profiles of tuberculosis disease activation among contacts of patients with tuberculosis Source: Eur Respir J, 54 (4) 1900353; 10.1183/13993003.00353-2019 Year: 2019 Surgical treatment of multidrug-resistant tuberculosis (MDR TB) Source: Eur Respir J 2003; 22: Suppl. 45, 523s Year: 2003 Potential role of autologous mesenchymal stromal cells in the treatment of multidrug and extensively drug-resistant tuberculosis Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Surgical treatment of destructive pulmonary tuberculosis (TB) with multi-drug resistance (MDR) Source: Eur Respir J 2004; 24: Suppl. 48, 723s Year: 2004 Primary multidrug resistance (PMDR) of mycobacterium tuberculosis (MBT) to antimycobacterial drugs (AMBTD) in the patients with destructive TB. Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Cytokine profile in patients with widespread MDR tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 504s Year: 2006 Polymorphisms in human NRF2 is associated with susceptibility to tuberculosis Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Treatment results of multidrug resistant pulmonary tuberculosis (MDR-TB) Source: Eur Respir J 2005; 26: Suppl. 49, 199s Year: 2005 The main causes which are responsible for secondary chemoresistance of Mycobacterium tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 524s Year: 2003 Nonspecific microflora in patients associated with pulmonary multidrug-resistant tuberculosis Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015